Global Diclofenac Market Size, by Indication (Osteoarthritis, Dysmenorrhea, Migraine), Route of Administration (Oral, Parental) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1089550
  • |
  • Date : June-2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Diclofenac Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The market is primarily driven by increasing prevalence of autoimmune and respiratory conditions such as arthritis & dermatomyositis. However, side effects of anti-inflammatory drugs and patent expiry issues of drugs might hamper the market growth.

The global diclofenac market is primarily segmented based on different indication, route of administration and regions.

On the basis of indication, the market is split into:
* Osteoarthritis
* Ankylosing Spondylitis
* Dysmenorrhea
* Rheumatoid Arthritis
* Migraine
* Pain
* Others

On the basis of route of administration, the market is split into:
* Oral
* Parenteral

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Auro Laboratories Limited
* Henan Dongtai Pharmaceutical Co.
* Bayer AG
* Pfizer Inc.
* Hunan Warrant Pharmaceutical Co., Ltd
* Novartis AG
* XianShi Pharmaceutical Group
* Merck & Co., Inc.
* Istituto Biochimico Italiano G. Lorenzini S.p.A.
* Dezhou Deyao Pharmaceutical Co., Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, indication and route of administration market size and their forecast from 2019-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, indication and route of administration with qualitative and quantitative information and facts

Target Audience:
* Diclofenac Drug Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Diclofenac Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Diclofenac Market - Porter\'s Five Forces Analysis
4.4. Global Diclofenac Market - PESTEL Analysis

5. Global Diclofenac Market, by Indication
5.1. Global Diclofenac Market, Size and Forecast, 2015-2026
5.2. Global Diclofenac Market, by Osteoarthritis, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Diclofenac Market, by Ankylosing Spondylitis, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Diclofenac Market, by Dysmenorrhea, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Diclofenac Market, by Rheumatoid Arthritis, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Diclofenac Market, by Migraine, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026
5.7. Global Diclofenac Market, by Pain, 2015-2026
5.7.1. Key driving factors, trends and opportunities
5.7.2. Market size and forecast, 2015-2026
5.8. Global Diclofenac Market, by Others, 2015-2026
5.8.1. Key driving factors, trends and opportunities
5.8.2. Market size and forecast, 2015-2026

6. Global Diclofenac Market, by Route of Administration
6.1. Global Diclofenac Market, Size and Forecast, 2015-2026
6.2. Global Diclofenac Market, by Oral, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Diclofenac Market, by Parental, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global Diclofenac Market by Region
7.1. Diclofenac Market Regional Analysis, 2015-2026
7.2. Global Diclofenac Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Diclofenac Market, 2015-2026
7.3.1. North America Diclofenac Market Size and Forecast, 2015-2026
7.3.2. North America Diclofenac Market by Country, 2015-2026
7.3.2.1. U.S. Diclofenac Market, 2015-2026
7.3.2.2. Canada Diclofenac Market, 2015-2026
7.4. Europe Diclofenac Market, 2015-2026
7.4.1. Europe Diclofenac Market Size and Forecast, 2015-2026
7.4.2. Europe Diclofenac Market by Country, 2015-2026
7.4.2.1. Germany Diclofenac Market, 2015-2026
7.4.2.2. France Diclofenac Market, 2015-2026
7.4.2.3. Italy Diclofenac Market, 2015-2026
7.4.2.4. UK Diclofenac Market, 2015-2026
7.4.2.5. Spain Diclofenac Market, 2015-2026
7.4.2.6. Rest of Europe Diclofenac Market, 2015-2026
7.5. Asia Pacific Diclofenac Market, 2015-2026
7.5.1. Asia Pacific Diclofenac Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Diclofenac Market by Country, 2015-2026
7.5.2.1. Japan Diclofenac Market, 2015-2026
7.5.2.2. China Diclofenac Market, 2015-2026
7.5.2.3. India Diclofenac Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Diclofenac Market, 2015-2026
7.6. South America Diclofenac Market, 2015-2026
7.6.1. South America Diclofenac Market Size and Forecast, 2015-2026
7.6.2. South America Diclofenac Market by Country, 2015-2026
7.6.2.1. Mexico Diclofenac Market, 2015-2026
7.6.2.2. Brazil Diclofenac Market, 2015-2026
7.6.2.3. Rest of South America Diclofenac Market, 2015-2026
7.7. Middle East & Africa Diclofenac Market, 2015-2026
7.7.1. Middle East & Africa Diclofenac Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Diclofenac Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Diclofenac Market, 2015-2026
7.7.2.2. South Africa Diclofenac Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Diclofenac Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Auro Laboratories Limited
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Henan Dongtai Pharmaceutical Co.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Bayer AG
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Pfizer Inc.
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Hunan Warrant Pharmaceutical Co., Ltd
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Novartis AG
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. XianShi Pharmaceutical Group
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Merck & Co., Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Istituto Biochimico Italiano G. Lorenzini S.p.A.
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Dezhou Deyao Pharmaceutical Co., Ltd.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type